CSIMarket Company Name, Ticker, Customers, else..
 
Vanda Pharmaceuticals Inc   (NASDAQ: VNDA)
 

VNDA's Market share relative to its competitors, as of Q3 2026

As of Q3 2026 (Revenue in Millions of $)

Date modified: 2026-10-30T13:34:51+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q3 2026		 MARKET SHARE
12 Months
Q3 2026		 MARKET SHARE
MRQ
Q3 2026		 MARKET SHARE
A Quarter Before
Q2 2026
Vanda Pharmaceuticals Inc 229.28 0.06% 0.07 % 0.03 %
Astrazeneca Plc 58,739.00 15.98% 15.98% 29.13%
Merck and Co Inc 66,569.00 18.11% 17.27% 8.77%
Pfizer Inc 63,625.00 17.31% 17.25% 8.10%
Sanofi 49,307.90 13.42% 13.42% 23.95%
Takeda Pharmaceutical Company Limited 30,079.37 8.18% 8.18% 15.91%
59 more competitors available

Sign in to see all competitors for Vanda Pharmaceuticals Inc .

Sign In Create Free Account



VNDA's Market share relative to its competitors, as of Q3 2026 within the Major Pharmaceutical Preparations Industry
As of Q3 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2026		 MARKET SHARE
12 Months Ending
Q2 2026		 MARKET SHARE
MRQ
Q3 2026		 MARKET SHARE

Q2 2026
Vanda Pharmaceuticals Inc 0.06% 0.07% 0.07 % 0.03 %
Astrazeneca Plc 15.98% 14.01% 15.98% 29.13%
Merck and Co Inc 18.11% 19.89% 17.27% 8.77%
Pfizer Inc 17.31% 19.14% 17.25% 8.10%
Sanofi 13.42% 15.17% 13.42% 23.95%
Takeda Pharmaceutical Company Limited 8.18% 8.92% 8.18% 15.91%
58 more companies available

Sign in to see all industry competitors for Vanda Pharmaceuticals Inc .

Sign In Create Free Account



VNDA's Market share relative to its competitors, as of Q3 2026 within the Healthcare Sector
As of Q3 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2026		 MARKET SHARE
12 Months Ending
Q2 2026		 MARKET SHARE
MRQ
Q3 2026		 MARKET SHARE

Q2 2026
Vanda Pharmaceuticals Inc 0.06% 0.07% 0.07 % 0.03 %
Astrazeneca Plc 15.98% 14.01% 15.98% 29.13%
Merck and Co Inc 18.11% 19.89% 17.27% 8.77%
Pfizer Inc 17.31% 19.14% 17.25% 8.10%
Sanofi 13.42% 15.17% 13.42% 23.95%
Takeda Pharmaceutical Company Limited 8.18% 8.92% 8.18% 15.91%
58 more companies available

Sign in to see all sector competitors for Vanda Pharmaceuticals Inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Vanda Pharmaceuticals Inc's market divisions, geographic dispersion, segments, products, and services, visit Vanda Pharmaceuticals Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.